Yuko Amizaki

Business Analyst

Yuko Amizaki joined Burrill & Company as Business Analyst in 2011. Yuko provides support for the decision making processes associated specifically with biogreentech and the Malaysian Life Sciences Capital Fund investments, and more generally in the life sciences. Yuko recently graduated from MIT Sloan School of Management with an MBA. She worked in corporate planning at Regimmune, a drug development biotech in Mountain View, CA. Previously, she was a consultant at Booz and Company in Tokyo, Japan. She holds a master of science in biology and bachelor of agriculture in applied life science.